BioCentury
ARTICLE | Company News

Sequenom, GlaxoSmithKline deal

September 4, 2001 7:00 AM UTC

GSK will participate in SQNM's project to generate a genome-wide SNP assay portfolio to screen the human genome for genes associated with diseases and adverse drug reactions. GSK will receive access t...